Author:
Das Sabya Sachi,Moitra Ishan,Das Subhrajeet,Singh Neeru,Verma Priya Ranjan Prasad,Singh Sandeep Kumar
Publisher
Springer Nature Singapore
Reference96 articles.
1. Alizadeh L, Alizadeh E, Zarebkohan A, Ahmadi E, Rahmati-Yamchi M, Salehi R (2020) AS1411 aptamer-functionalized chitosan-silica nanoparticles for targeted delivery of epigallocatechin gallate to the Skov-3 ovarian cancer cell lines. J Nanopart Res 22(1):9123. https://doi.org/10.1007/s11051-019-4735-7
2. Amini A, Masoumi Moghaddam S, Morris DL, Pourgholami MH (2012) Utility of vascular endothelial growth factor inhibitors in the treatment of ovarian cancer: from concept to application. J Oncol 2012:540791. https://doi.org/10.1155/2012/540791
3. Astete CE, Sabliov CM (2006) Synthesis and characterization of PLGA nanoparticles. J Biomater Sci Polym Ed 17(3):247–289. https://doi.org/10.1163/156856206775997322
4. AstraZeneca (2016, December-2021, January) Olaparib tablets as a treatment for ovarian cancer subjects with different hrd tumor status. Identifier NCT02983799. https://clinicaltrials.gov/ct2/show/NCT02983799?term=olaparib &recrs=e&cond=Ovarian+Cancer&draw=2&rank=5. Accessed on 14 Jan, 2022
5. Babu A, Wang Q, Muralidharan R, Shanker M, Munshi A, Ramesh R (2014) Chitosan coated polylactic acid nanoparticle-mediated combinatorial delivery of cisplatin and siRNA/plasmid DNA chemosensitizes cisplatin-resistant human ovarian cancer cells. Mol Pharm [Internet] 11(8):2720–2733. https://doi.org/10.1021/mp500259e. Accessed on 28, Nov, 2021